Medical Research
(H99)
990 on File
TUMORI
Financial strength (30%)
62/100
Reliability (20%)
55/100
Effectiveness (25%)
21/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2024
$381K
Total Revenue
$105K
Total Expenses
$3.4M
Net Assets
N/A
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
40.1%
Fundraising Efficiency
N/A
Operating Reserve
386.15x
Liability-to-Asset
0.0%
Revenue Diversification
63.0%
Executive Compensation
$0
Compared with Peers
FY 2024
Compared with 726 similar organizations
(United States, Medical Research, $100K–$1M in expenses), FY 2024.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
40.1% | 84.5% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
386.2 mo | 13.4 mo |
P10P90
|
Top quarter |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.4% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
63.0% | 93.3% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
-362.5% | 9.1% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
-66.8% | 8.8% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
72.3% | 1.8% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2024 | $381K | $105K | $3.4M | 40.1% | — |
| 2023 | $-145,062 | $317K | $2.8M | 85.9% | — |
| 2022 | $25K | $121K | $2.6M | 52.4% | — |
| 2019 | $205K | $229K | N/A | — | 3 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.